Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies is a research paper published in Molecular Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Centre for Digital Life Norway
Grant: 294916
DL: Pipeline for individually tailoring new treatments in hematological cancers (PINpOINT)
National Institutes of Health
Grant: R01 CA 213442
The Research Council of Norway
Grant: 215850
ATLANTIS: socioECOnomics and ECOsystembased fisheries management
The Research Council of Norway
Grant: 262652
Centre for Cancer Cell Reprogramming (CanCell)
Stiftelsen Kristian Gerhard Jebsen
FWCI
1.63
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals